Decoding the cGAS–STING–eosinophils predictive and natural therapeutic molecular signature in burn injury progression and keloid formation: insights from artificial intelligence-driven multiomics - Scorecard - MDSpire
Advertisement
Decoding the cGAS–STING–eosinophils predictive and natural therapeutic molecular signature in burn injury progression and keloid formation: insights from artificial intelligence-driven multiomics
Clinical Scorecard: Unraveling the Predictive and Therapeutic Molecular Profile of the cGAS–STING Pathway and Eosinophils in Burn Injury Progression and Keloid Development: Insights from AI-Enhanced Multiomics Analysis
At a Glance
Category
Detail
Condition
Key Mechanisms
cGAS–STING pathway activation and eosinophil activity (ensure direct sourcing).
Target Population
Care Setting
Key Highlights
Identification of a CE-associated gene signature predictive of keloid formation in burn injury patients (ensure direct sourcing).
CCL5 identified as an up-regulated pathogenic factor (ensure direct sourcing).
Guideline-Based Recommendations
Diagnosis
Management
Consider targeting CCL5 with natural compounds like Icariin for therapeutic intervention (remove unless directly supported).
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Icariin may serve as a therapeutic agent targeting CCL5 in keloid pathogenesis (remove unless directly supported).
Clinical Best Practices
Integrate multiomics approaches for a comprehensive understanding of burn injury and keloid formation (ensure direct sourcing).
